FDA clears Elscint multislice CT scanner

Article

Israeli medical imaging vendor Elscint has received 510(k) clearance for its version of a multislice CT scanner developed in partnership with Siemens Medical Systems of Iselin, NJ. The scanner is called Volumax CT Imaging System in Elscint’s 510(k)

Israeli medical imaging vendor Elscint has received 510(k) clearance for its version of a multislice CT scanner developed in partnership with Siemens Medical Systems of Iselin, NJ. The scanner is called Volumax CT Imaging System in Elscint’s 510(k) application, which was cleared on Sept. 2.

Volumax is based on the same technology used in Siemens’ Somatom Plus 4 Volume Zoom scanner, with some differences in components, according to an Elscint spokesperson. The system will probably be ready to ship in January.

Elscint and Siemens signed a CT technology development partnership in 1996 that culminated in the development of the Volume Zoom and Volumax scanners (SCAN 10/14/98). Each company has rights to sell its version of the technology under the terms of the deal. Picker International’s pending acquisition of Elscint’s CT division will probably give the Cleveland vendor rights to sell Volumax, according to the Elscint spokesperson.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.